Related Experiment Videos
[Specific meningeal involvement in multiple myeloma]
Presse Medicale (Paris, France : 1983)
|March 30, 1985
Abstract:
Meningeal involvement is extremely rare in multiple myeloma. Its characteristic features can be derived from the 3 cases presented here and from the 11 cases previously published. Specific signs of meningeal myelomatosis include convulsions, confusion, cranial nerve palsies and plasma cells in the cerebrospinal fluid. Meningitis develops in patients with high tumoral mass myeloma, leukaemic in one-half of the cases. Treatment is ineffective, and death occurs within a few months.
Insights
Meningeal involvement in multiple myeloma is rare but serious. Key signs include seizures, confusion, and cranial nerve palsies, often seen in advanced or leukaemic myeloma cases.
Area of Science:
- Hematology
- Neurology
- Oncology
Background:
- Multiple myeloma is a cancer of plasma cells.
- Meningeal involvement is an uncommon complication.
Observation:
- Presents 3 new cases and reviews 11 prior cases of meningeal myelomatosis.
- Identifies characteristic clinical and cerebrospinal fluid findings.
Findings:
- Specific signs include seizures, confusion, cranial nerve palsies, and CSF plasma cells.
- Meningeal myelomatosis often occurs in patients with high tumor burden or leukaemic myeloma.
- Treatment is largely ineffective, with a poor prognosis.
Implications:
- Highlights the importance of recognizing rare neurological presentations of multiple myeloma.
- Suggests the need for improved diagnostic strategies and therapeutic approaches for meningeal myelomatosis.